A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease

Study Status

Open to Enrollment

Study Description

This research study is for pregnant women who have either Crohn’s disease or ulcerative colitis.

The study is being conducted to determine whether the rates of birth defects, miscarriages, premature births and other outcomes in women with inflammatory bowel disease (IBD) taking azathioprine/6MP or anti-TNF therapy (Remicade, Humira, Cimzia) are different from those among women with IBD who are taking these medications. Little is known about the effects of these medications on pregnant women and their babies. This information will be valuable in guiding the therapy of women with Crohn’s disease or ulcerative colitis who wish to have children while receiving therapy for their illness.

Study participants will be asked to complete questionnaires when they enter the study, during each trimester of their pregnancy, at delivery and at 4, 9, and 12 months after the birth of their baby. 

Disease Status and/or Stage

Pregnant Women with Crohn's Disease or Ulcerative Colitis

Sponsor

Crohn’s Colitis Foundation Clinical Alliance

Key Eligibility

  • Pregnant women with Crohn's disease or ulcerative colitis
  • Age 18 to 50

Principal Investigator

Ellen Scherl, MD

Contact

  • Jill Roberts Center for Inflammatory Bowel Disease
  • (212) 746-5077

Healthy Volunteers

healthy_volunteers.jpg

As a healthy volunteer in a clinical trial you may make a significant contribution to the discovery of medical knowledge and new treatments that could impact people around the world.
Click here for studies seeking healthy volunteers.

Contact Us

For general inquiries, or if you need assistance finding a study, please contact:

Robert Hagerty
Subject Recruitment Manager
Tel: (646) 962-9340
[email protected]

Top of page